Rack up another win for Big Pharma: Their new anti-COVID drugs do what Ivermectin and hydroxychloroquine already do -- effectively treat COVID
Big Pharma is celebrating. Merck has released "phenomenal" test results for its experimental pill for treating COVID. The drug is said to greatly reduce the risk of hospitalization and death from the Wuhan virus. In this regard, Merck has beaten Pfizer, which is also deep in developing a medicine to treat COVID. And to be perfectly clear, both Merck and Pfizer drugs are not intended to prevent COVID. They treat it.
And since the Merck drug is said to be significantly different from Pfizer's, it means, according to many experts, there is a strong likelihood of creating a cocktail of anti-viral treatments for the Wuhan virus. This is indeed good news... except for one thing.
If the first-hand experience of many front-line doctors is to believed, these new anti-COVID drugs do what Ivermectin and hydroxychloroquine already do -- effectively treat COVID. Led by Big Pharma, the medical establishment has denigrated Ivermectin and hydroxychloroquine as "not approved for COVID treatment." These drugs have been driven into the shadows and mocked from highly credentialed medical people to airhead celebrities to the ill-informed neighbor living next door.
Here's a cynic's view of the situation. The reason for the jihad against Ivermectin and hydroxychloroquine was not the health of the public. It's that both these drugs are low-cost generics. Their use would not garner large profits for Big Pharma. But the new Merck and Pfizer drug will surely cost a pretty penny. Why? It's to capture their R&D costs which the accountants at Big Pharma are well experienced in bloating. And even if some decree by one of the alphabet health agencies in Washington says the Merck and Pfizer drugs should be made available to the public at low cost or for free, the true cost will be eventually be absorbed by Uncle Sam
Rack up another win for Big Pharma - American Thinker